As a drug developer, the cost and speed of sequencing is not nearly as important as the results it can achieve. Biomarker discovery. Drug target identification. Personalised medicine. RNA-seq. Metagenomics. The opportunities seem endless.

NGS Pharma is Europe’s only commercial meeting to focus exclusively on the applications of next generation sequencing. Discover the latest advances in sequencing strategy and explore the most promising drug development programmes to boost the performance of your pipeline.

With input from experts at GSK, Merck, Novartis, the Sanger Institute and many more, this is a programme for the industry, by the industry. Hear the leaders address the problems that you are currently facing in your drug discovery and development programmes and the role that next-generation sequencing can play.

Bringing together pharma, biotechs, research institutes and leading technology and solution providers, this meeting will provide an unbeatable, unmissable opportunity. Share best practices, learn from the leaders and come together to discuss the best methods to harness the potential of next generation sequencing technologies to reduce drug development costs and improve the performance of your pipeline.

Expect open and lively discussion, great networking opportunities, new solutions to seemingly impossible challenges, and a raft of groundbreaking ideas to take back to your organisation and transform your research and business opportunities.